Life Sciences Tools and Services
Company Overview of Nanotether Discovery Science Ltd
Nanotether Discovery Science Ltd develops a technology platform for studying biomolecular interactions in life sciences, particularly for applications streamlining the drug discovery process. Its technology accelerates drug discovery by miniaturizing and accelerating the rate at which interactions between proteins and drug candidates can be studied for the pharmaceutical and biotechnology markets. The company was founded in 2012 and is based in Cardiff, United Kingdom. As of April 25, 2017, Nanotether Discovery Science Ltd operates as a subsidiary of Belluscura Ltd.
Cardiff, CF14 4UJ
Founded in 2012
44 29 2068 2051
Key Executives for Nanotether Discovery Science Ltd
Nanotether Discovery Science Ltd does not have any Key Executives recorded.
Similar Private Companies By Industry
|14M Genomics Ltd||Europe|
|Ablatus Therapeutics Limited||Europe|
|Accuro Biologics Ltd.||Europe|
Recent Private Companies Transactions
April 25, 2017
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|Bloomberg L.P.||United States|
|The Advertising Council, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Nanotether Discovery Science Ltd, please visit www.nanotether.co.uk. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.